
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ™ (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients.
All tasks are to be performed in compliance with GCP and Idorsia SOPs.
At Idorsia, we are committed to improving patient outcomes through innovation, collaboration, and excellence. If you are a strategic leader passionate about developing teams, driving results, and making a meaningful impact in healthcare, we encourage you to apply. We value diversity and are committed to creating an inclusive workplace for all.

The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients.
We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options.
In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core.
Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
See our LinkedIn community guidelines: https://bit.ly/4nAfOZp
Idorsia privacy policy: https://www.idorsia.com/legal/privacy-policy